Cargando…

Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies

INTRODUCTION: Relentless placoid chorioretinitis (RPC) is a rare, bilateral disease of the retinal pigment epithelium. The clinical course is prolonged and relapsing. No standard treatment has been established to date. The purpose of this case series is to report four cases of RPC in pediatric and y...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaheer, Haniah A., Odden, Jamie, Gagrani, Meghal, Zaguia, Fatma, Lowder, Careen, Coca, Andreea, Rosenkranz, Margalit E., Patil-Chhablani, Preeti, Ores, Raphaelle, Boussion, Francois, Indermill, Chad, Sahel, José-Alain, Nischal, Ken, Goldstein, Debra A., Errera, Marie-Helene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083237/
https://www.ncbi.nlm.nih.gov/pubmed/37051435
http://dx.doi.org/10.3389/fped.2023.885230
_version_ 1785021463142596608
author Zaheer, Haniah A.
Odden, Jamie
Gagrani, Meghal
Zaguia, Fatma
Lowder, Careen
Coca, Andreea
Rosenkranz, Margalit E.
Patil-Chhablani, Preeti
Ores, Raphaelle
Boussion, Francois
Indermill, Chad
Sahel, José-Alain
Nischal, Ken
Goldstein, Debra A.
Errera, Marie-Helene
author_facet Zaheer, Haniah A.
Odden, Jamie
Gagrani, Meghal
Zaguia, Fatma
Lowder, Careen
Coca, Andreea
Rosenkranz, Margalit E.
Patil-Chhablani, Preeti
Ores, Raphaelle
Boussion, Francois
Indermill, Chad
Sahel, José-Alain
Nischal, Ken
Goldstein, Debra A.
Errera, Marie-Helene
author_sort Zaheer, Haniah A.
collection PubMed
description INTRODUCTION: Relentless placoid chorioretinitis (RPC) is a rare, bilateral disease of the retinal pigment epithelium. The clinical course is prolonged and relapsing. No standard treatment has been established to date. The purpose of this case series is to report four cases of RPC in pediatric and young adult patients in which varying treatments were used, comparing them to previously published cases. METHODS: A literature review was conducted to investigate currently published presentations and treatment options for RPC. A multicenter retrospective chart review was also performed on four consecutive patients. These patients were diagnosed with RPC because of new chorioretinitis lesions continuing to appear without or despite therapy for 5–36 months (2 patients), with a clinical course prolonged and relapsing, or because of the atypical location of the multiple lesions (>50) extending from the posterior pole to the equator and mid-peripheral retina (all four patients), which were not consistent with other entities like acute posterior multifocal placoid pigment epitheliopathy and serpiginous choroiditis. RESULTS: All four cases of RPC received oral or IV steroids acutely, and three of these patients were transitioned to a steroid-sparing agent and biologic therapy: anti-TNF alpha or anti-IL-6. Quiescence of the chorioretinitis lesions was obtained after 7 months, 1 month, and 36 months; however, the latter had issues with treatment adherence. Mycophenolate mofetil was insufficient to control the disease in one patient, but tocilizumab and infliximab thereafter were effective after cessation of adalimumab due to side effects. Adalimumab when started the first month after the presentation was effective in controlling the disease in one patient. After the failure of interferon-alpha-2a, one patient displayed long-term control with infliximab. One patient did not require a steroid-sparing agent after oral prednisone taper as there was no evidence of progression or recurrence. CONCLUSION: This case series adds to the current knowledge regarding potential treatments for RPC, specifically the use of anti-TNF-alpha treatment and anti-IL-6 tocilizumab. In this case study, relapses of RPC were found among patients on mycophenolate mofetil and interferon-alpha-2a, and one case did not relapse on oral steroids without a steroid-sparing agent. Our findings suggest that adalimumab, infliximab, and tocilizumab may be useful medications to obtain quiescence of RPC.
format Online
Article
Text
id pubmed-10083237
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100832372023-04-11 Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies Zaheer, Haniah A. Odden, Jamie Gagrani, Meghal Zaguia, Fatma Lowder, Careen Coca, Andreea Rosenkranz, Margalit E. Patil-Chhablani, Preeti Ores, Raphaelle Boussion, Francois Indermill, Chad Sahel, José-Alain Nischal, Ken Goldstein, Debra A. Errera, Marie-Helene Front Pediatr Pediatrics INTRODUCTION: Relentless placoid chorioretinitis (RPC) is a rare, bilateral disease of the retinal pigment epithelium. The clinical course is prolonged and relapsing. No standard treatment has been established to date. The purpose of this case series is to report four cases of RPC in pediatric and young adult patients in which varying treatments were used, comparing them to previously published cases. METHODS: A literature review was conducted to investigate currently published presentations and treatment options for RPC. A multicenter retrospective chart review was also performed on four consecutive patients. These patients were diagnosed with RPC because of new chorioretinitis lesions continuing to appear without or despite therapy for 5–36 months (2 patients), with a clinical course prolonged and relapsing, or because of the atypical location of the multiple lesions (>50) extending from the posterior pole to the equator and mid-peripheral retina (all four patients), which were not consistent with other entities like acute posterior multifocal placoid pigment epitheliopathy and serpiginous choroiditis. RESULTS: All four cases of RPC received oral or IV steroids acutely, and three of these patients were transitioned to a steroid-sparing agent and biologic therapy: anti-TNF alpha or anti-IL-6. Quiescence of the chorioretinitis lesions was obtained after 7 months, 1 month, and 36 months; however, the latter had issues with treatment adherence. Mycophenolate mofetil was insufficient to control the disease in one patient, but tocilizumab and infliximab thereafter were effective after cessation of adalimumab due to side effects. Adalimumab when started the first month after the presentation was effective in controlling the disease in one patient. After the failure of interferon-alpha-2a, one patient displayed long-term control with infliximab. One patient did not require a steroid-sparing agent after oral prednisone taper as there was no evidence of progression or recurrence. CONCLUSION: This case series adds to the current knowledge regarding potential treatments for RPC, specifically the use of anti-TNF-alpha treatment and anti-IL-6 tocilizumab. In this case study, relapses of RPC were found among patients on mycophenolate mofetil and interferon-alpha-2a, and one case did not relapse on oral steroids without a steroid-sparing agent. Our findings suggest that adalimumab, infliximab, and tocilizumab may be useful medications to obtain quiescence of RPC. Frontiers Media S.A. 2023-03-27 /pmc/articles/PMC10083237/ /pubmed/37051435 http://dx.doi.org/10.3389/fped.2023.885230 Text en © 2023 Zaheer, Odden, Gagrani, Zaguia, Lowder, Coca, Rosenkranz, Patil, Ores, Boussion,Indermill, Sedira, Sahel, Nischal, Goldstein and Errera. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Zaheer, Haniah A.
Odden, Jamie
Gagrani, Meghal
Zaguia, Fatma
Lowder, Careen
Coca, Andreea
Rosenkranz, Margalit E.
Patil-Chhablani, Preeti
Ores, Raphaelle
Boussion, Francois
Indermill, Chad
Sahel, José-Alain
Nischal, Ken
Goldstein, Debra A.
Errera, Marie-Helene
Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies
title Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies
title_full Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies
title_fullStr Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies
title_full_unstemmed Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies
title_short Relentless placoid chorioretinitis: A review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies
title_sort relentless placoid chorioretinitis: a review of four cases in pediatric and young adult patients with a discussion of therapeutic strategies
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083237/
https://www.ncbi.nlm.nih.gov/pubmed/37051435
http://dx.doi.org/10.3389/fped.2023.885230
work_keys_str_mv AT zaheerhaniaha relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT oddenjamie relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT gagranimeghal relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT zaguiafatma relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT lowdercareen relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT cocaandreea relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT rosenkranzmargalite relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT patilchhablanipreeti relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT oresraphaelle relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT boussionfrancois relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT indermillchad relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT saheljosealain relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT nischalken relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT goldsteindebraa relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies
AT erreramariehelene relentlessplacoidchorioretinitisareviewoffourcasesinpediatricandyoungadultpatientswithadiscussionoftherapeuticstrategies